466 related articles for article (PubMed ID: 20510730)
21. 4-1BB and OX40 stimulation enhance CD8 and CD4 T-cell responses to a DNA prime, poxvirus boost vaccine.
Munks MW; Mourich DV; Mittler RS; Weinberg AD; Hill AB
Immunology; 2004 Aug; 112(4):559-66. PubMed ID: 15270726
[TBL] [Abstract][Full Text] [Related]
22. Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses.
Ruby CE; Redmond WL; Haley D; Weinberg AD
Eur J Immunol; 2007 Jan; 37(1):157-66. PubMed ID: 17183611
[TBL] [Abstract][Full Text] [Related]
23. OX40 (CD134) engagement drives differentiation of CD4+ T cells to effector cells.
Huddleston CA; Weinberg AD; Parker DC
Eur J Immunol; 2006 May; 36(5):1093-103. PubMed ID: 16541471
[TBL] [Abstract][Full Text] [Related]
24. Anti-OX40 prevents effector T-cell accumulation and CD8+ T-cell mediated skin allograft rejection.
Kinnear G; Wood KJ; Marshall D; Jones ND
Transplantation; 2010 Dec; 90(12):1265-71. PubMed ID: 21037534
[TBL] [Abstract][Full Text] [Related]
25. Introduction of OX40 ligand into lymphoma cells elicits anti-lymphoma immunity in vivo.
Kaneko H; Hori T; Yanagita S; Kadowaki N; Uchiyama T
Exp Hematol; 2005 Mar; 33(3):336-43. PubMed ID: 15730857
[TBL] [Abstract][Full Text] [Related]
26. Signaling through OX40 (CD134) breaks peripheral T-cell tolerance.
Bansal-Pakala P; Jember AG; Croft M
Nat Med; 2001 Aug; 7(8):907-12. PubMed ID: 11479622
[TBL] [Abstract][Full Text] [Related]
27. OX40, OX40L and Autoimmunity: a Comprehensive Review.
Webb GJ; Hirschfield GM; Lane PJ
Clin Rev Allergy Immunol; 2016 Jun; 50(3):312-32. PubMed ID: 26215166
[TBL] [Abstract][Full Text] [Related]
28. Expression and function of OX40 ligand on human dendritic cells.
Ohshima Y; Tanaka Y; Tozawa H; Takahashi Y; Maliszewski C; Delespesse G
J Immunol; 1997 Oct; 159(8):3838-48. PubMed ID: 9378971
[TBL] [Abstract][Full Text] [Related]
29. Cooperation between CD4 and CD8 T cells for anti-tumor activity is enhanced by OX40 signals.
Song A; Song J; Tang X; Croft M
Eur J Immunol; 2007 May; 37(5):1224-32. PubMed ID: 17429847
[TBL] [Abstract][Full Text] [Related]
30. OX40/OX40L costimulation affects induction of Foxp3+ regulatory T cells in part by expanding memory T cells in vivo.
Xiao X; Kroemer A; Gao W; Ishii N; Demirci G; Li XC
J Immunol; 2008 Sep; 181(5):3193-201. PubMed ID: 18713990
[TBL] [Abstract][Full Text] [Related]
31. Expression and function of the OX40/OX40L costimulatory pair during herpes stromal keratitis.
Lepisto AJ; Xu M; Yagita H; Weinberg AD; Hendricks RL
J Leukoc Biol; 2007 Mar; 81(3):766-74. PubMed ID: 17185358
[TBL] [Abstract][Full Text] [Related]
32. Constitutive OX40/OX40 ligand interaction induces autoimmune-like diseases.
Murata K; Nose M; Ndhlovu LC; Sato T; Sugamura K; Ishii N
J Immunol; 2002 Oct; 169(8):4628-36. PubMed ID: 12370402
[TBL] [Abstract][Full Text] [Related]
33. High levels of costimulatory receptors OX40 and 4-1BB characterize CD4+CD28null T cells in patients with acute coronary syndrome.
Dumitriu IE; Baruah P; Finlayson CJ; Loftus IM; Antunes RF; Lim P; Bunce N; Kaski JC
Circ Res; 2012 Mar; 110(6):857-69. PubMed ID: 22282196
[TBL] [Abstract][Full Text] [Related]
34. OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response.
Jacquemin C; Schmitt N; Contin-Bordes C; Liu Y; Narayanan P; Seneschal J; Maurouard T; Dougall D; Davizon ES; Dumortier H; Douchet I; Raffray L; Richez C; Lazaro E; Duffau P; Truchetet ME; Khoryati L; MerciƩ P; Couzi L; Merville P; Schaeverbeke T; Viallard JF; Pellegrin JL; Moreau JF; Muller S; Zurawski S; Coffman RL; Pascual V; Ueno H; Blanco P
Immunity; 2015 Jun; 42(6):1159-70. PubMed ID: 26070486
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of OX40-induced apoptosis by TNF coactivation in OX40-expressing T cell lines in vitro leading to decreased targets for HIV type 1 production.
Takahashi Y; Tanaka R; Yamamoto N; Tanaka Y
AIDS Res Hum Retroviruses; 2008 Mar; 24(3):423-35. PubMed ID: 18327975
[TBL] [Abstract][Full Text] [Related]
36. OX40 (CD134) and OX40L.
Gough MJ; Weinberg AD
Adv Exp Med Biol; 2009; 647():94-107. PubMed ID: 19760068
[TBL] [Abstract][Full Text] [Related]
37. Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion.
Song J; So T; Cheng M; Tang X; Croft M
Immunity; 2005 May; 22(5):621-31. PubMed ID: 15894279
[TBL] [Abstract][Full Text] [Related]
38. OX40 and OX40L Interaction in Cancer.
Lu X
Curr Med Chem; 2021; 28(28):5659-5673. PubMed ID: 33372866
[TBL] [Abstract][Full Text] [Related]
39. OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy.
Shibahara I; Saito R; Zhang R; Chonan M; Shoji T; Kanamori M; Sonoda Y; Kumabe T; Kanehira M; Kikuchi T; So T; Watanabe T; Takahashi H; Iwabuchi E; Tanaka Y; Shibahara Y; Sasano H; Ishii N; Tominaga T
Mol Cancer; 2015 Feb; 14():41. PubMed ID: 25744203
[TBL] [Abstract][Full Text] [Related]
40. A diametric role for OX40 in the response of effector/memory CD4+ T cells and regulatory T cells to alloantigen.
Kinnear G; Wood KJ; Fallah-Arani F; Jones ND
J Immunol; 2013 Aug; 191(3):1465-75. PubMed ID: 23817421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]